Literature DB >> 21534906

A synthetic haemoglobin-based oxygen carrier and the reversal of cardiac hypoxia secondary to severe anaemia following trauma.

Mark C Fitzgerald1, Julie Y Chan, Andrew W Ross, Susan M Liew, Warwick W Butt, David Baguley, Hatem H Salem, Matthias K Russ, Conor Deasy, Katherine E Martin, Joseph K Mathew, Jeffrey V Rosenfeld.   

Abstract

We report a case of compassionate use of a haemoglobin-based oxygen carrier in a severely injured Jehovah's Witness patient, for whom survival was considered unlikely. Severe anaemia and cardiac hypoxia were reversed after slow infusion of this agent. No vasoactive side effects were associated with the treatment, possibly due to the slow infusion, and the patient survived.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21534906     DOI: 10.5694/j.1326-5377.2011.tb03064.x

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  9 in total

Review 1.  Blood substitutes: why haven't we been more successful?

Authors:  Abdu I Alayash
Journal:  Trends Biotechnol       Date:  2014-03-12       Impact factor: 19.536

Review 2.  Oxidative pathways in the sickle cell and beyond.

Authors:  Abdu I Alayash
Journal:  Blood Cells Mol Dis       Date:  2017-05-20       Impact factor: 3.039

3.  Autoxidation and oxygen binding properties of recombinant hemoglobins with substitutions at the αVal-62 or βVal-67 position of the distal heme pocket.

Authors:  Ming F Tam; Natalie W Rice; David H Maillett; Virgil Simplaceanu; Nancy T Ho; Tsuey Chyi S Tam; Tong-Jian Shen; Chien Ho
Journal:  J Biol Chem       Date:  2013-07-18       Impact factor: 5.157

4.  Differential heme release from various hemoglobin redox states and the upregulation of cellular heme oxygenase-1.

Authors:  Tigist Kassa; Sirsendu Jana; Fantao Meng; Abdu I Alayash
Journal:  FEBS Open Bio       Date:  2016-08-08       Impact factor: 2.693

Review 5.  Hemoglobin-Based Blood Substitutes and the Treatment of Sickle Cell Disease: More Harm than Help?

Authors:  Abdu I Alayash
Journal:  Biomolecules       Date:  2017-01-04

Review 6.  Fluids of the Future.

Authors:  Thomas H Edwards; Guillaume L Hoareau
Journal:  Front Vet Sci       Date:  2021-01-21

7.  The Providence Mutation (βK82D) in Human Hemoglobin Substantially Reduces βCysteine 93 Oxidation and Oxidative Stress in Endothelial Cells.

Authors:  Sirsendu Jana; Michael Brad Strader; Abdu I Alayash
Journal:  Int J Mol Sci       Date:  2020-12-11       Impact factor: 5.923

8.  Hemoglobin-Based Oxygen Carrier for Traumatic Hemorrhagic Shock Treatment in a Jehovah's Witness.

Authors:  Joseph A Posluszny; Lena M Napolitano
Journal:  Arch Trauma Res       Date:  2016-02-02

9.  Mechanisms of Toxicity and Modulation of Hemoglobin-based Oxygen Carriers.

Authors:  Abdu I Alayash
Journal:  Shock       Date:  2019-10       Impact factor: 3.454

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.